Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
November 15, 2013
October 16, 2013
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
August 12, 2013
An international study on epilepsy has uncovered 25 new mutations on nine key genes that could pave the way to develop precise therapies for a devastating form of the disorder during childhood.
July 02, 2013
A UCSF-led team has discovered that vitamin C affects whether genes are switched on or off inside mouse stem cells, suggesting that it may play fundamental role in helping to guide normal development.
June 27, 2013
A new UCSF study highlights the potential importance of the vast majority of human DNA that lies outside of genes within the cell.
June 13, 2013
The scientific community at UCSF is reacting positively to the Supreme Court’s unanimous ruling that human genes cannot be patented.
May 03, 2013
The tick-borne Lone Star virus has been conclusively identified as part of a family of other tick-borne viruses called bunyaviruses, which often cause fever, respiratory problems and bleeding, according to new research led by scientists at UC San Francisco (UCSF).
May 01, 2013
A UCSF-led research team has identified a genetic mutation that is strongly associated with a typical form of migraine. The discovery could lead to more effective therapies for people with this condition.
April 16, 2013
A new UCSF study has found a clear association between certain genes and the development of lymphedema, a painful and chronic condition that often occurs after breast cancer surgery and some other cancer treatments.
April 03, 2013
Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers who have outlined their vision of cell-based therapeutics as a “third pillar of medicine."